These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15134485)

  • 1. Drug delivery systems for brain tumor therapy.
    Rautioa J; Chikhale PJ
    Curr Pharm Des; 2004; 10(12):1341-53. PubMed ID: 15134485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
    Gao H
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
    Wu L; Li X; Janagam DR; Lowe TL
    Pharm Res; 2014 Mar; 31(3):531-40. PubMed ID: 23996470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches.
    Shah V; Kochar P
    Recent Pat Anticancer Drug Discov; 2018; 13(1):70-85. PubMed ID: 29189177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.
    Serwer LP; James CD
    Adv Drug Deliv Rev; 2012 May; 64(7):590-7. PubMed ID: 22306489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
    Wang Z; Sun H; Yakisich JS
    Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
    Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
    Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Drug Delivery via Folate Receptors for the Treatment of Brain Cancer: Can the Promise Deliver?
    Guo J; Schlich M; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2017 Dec; 106(12):3413-3420. PubMed ID: 28842300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors.
    Calabrese G; De Luca G; Nocito G; Rizzo MG; Lombardo SP; Chisari G; Forte S; Sciuto EL; Conoci S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood brain barrier: a challenge for effectual therapy of brain tumors.
    Bhowmik A; Khan R; Ghosh MK
    Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.